Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care

NCT02084719 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

67

Enrollment

OTHER

Sponsor class

Stopped Slow recruitement

Conditions

Active or Ex-injection Drug Users
Indication of Hepatitis C Screening

Interventions

DEVICE: Oraquick HCV Rapid Antibody Test
DEVICE: Standard algorithm

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

[object Object]